Skip to main content

Table 4 Details of the PFT results of included cases

From: Evaluation of safety and efficacy of allogeneic adipose tissue-derived mesenchymal stem cells in pediatric bronchiolitis obliterans syndrome (BoS) after allogeneic hematopoietic stem cell transplantation (allo-HSCT)

Pt. no

Parameter

PFT (% to predicted, months)

− 2

0

1

3

6

8

12

21

1*

FEV1

N/A

29

35

35

33

N/A

N/A

N/A

 

FEV1/FVC

 

45

42

42

41

   
 

SpO2 (%)

 

95

96

97

95

   

2*

FEV1

N/A

28

28

33

32

38

32

23

 

FEV1/FVC

 

45

41

45

42

50

55

51

 

SpO2 (%)

 

92

93

96

96

96

96

94

3

FEV1

35

N/A

45

43

N/A

N/A

N/A

N/A

 

FEV1/FVC

47

 

45

44

    
 

SpO2 (%)

96†

 

96

96

    

4*

FEV1

42

N/A

38

34

32

N/A

N/A

N/A

 

FEV1/FVC

74

 

75

54

51

   
 

SpO2 (%)

98†

 

95

94

95

   
  1. FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, N/A not available, no number, PFT pulmonary function test, SpO2, oxygen saturation
  2. *Documented evidence of corticosteroid-induced osteoporosis
  3. †With oxygen supplementation
Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512